Mirae Asset Global Investments Co., Ltd. Olema Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,484 shares of OLMA stock, worth $13,537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,484
Previous 1,909
30.12%
Holding current value
$13,537
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding OLMA
# of Institutions
155Shares Held
67.6MCall Options Held
235KPut Options Held
1.3K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$40.7 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$39.8 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$31.2 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$21.8 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$20 Million0.05% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $220M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...